Jana Karolova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy.
Journal: American journal of hematology
Published: May 18, 2023
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 26, 2022
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas.
Journal: Molecular cancer therapeutics
Published: June 09, 2021
Current Immunotherapy Approaches in Non-Hodgkin Lymphomas.
Journal: Vaccines
Published: October 30, 2020
Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma.
Journal: Acta biomaterialia
Published: August 19, 2020
PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population.
Journal: Folia biologica
Published: January 01, 2020
Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 05, 2019
Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2018
Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
Journal: The British journal of ophthalmology
Published: November 09, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026